產(chǎn)品名稱 |
Human astrovirus |
商品貨號(hào) |
B162799 |
Classification |
Astroviridae, Mamastrovirus, Mamastrovirus 2 |
Agent |
Human astrovirus |
Strain |
Type 2 |
Applications |
Virucide testing
In vitro infectivity assay
Antiviral Studies
Spiking studies
ELISpot Assay
Virus neutralization assay
Virus ultrastructural studies
Immunological-based assays
PCR-based assay validation
Research and development
Assay development
Vaccine development |
Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Product Format |
frozen 1.0 mL per vial |
Storage Conditions |
-70°C or colder |
Images |
|
Comments |
Freeze-thaw twice at harvest. |
Effect on Host |
CPE may not be visible – confirm infection by IFA. Sloughing and detachment may result from trypsin supplemented growth medium. |
Recommended Host |
CaCo-2 cells (ATCC® HTB-37™) |
Growth Conditions |
Temperature: 37°C
Recommendations for Infection: Plate cells 18-24 hours prior to infection and infect when cultures are 90-100% confluent. Pre-treat inoculum in EMEM (ATCC® 30-2003™) + 5 μg/mL 1X-S trypsin (Sigma-Aldrich® T0303) for 30 minutes at 37°C. Remove medium from host cells and rinse twice with 1X DPBS. Inoculate with a small volume of virus (e.g. 1 mL per 25 cm2) diluted to provide an optimal MOI (0.1 to 1.0). Adsorb 1 hour at 37°C in a humidified 5% CO2 atmosphere. End adsorption by removing inoculum and adding virus growth medium.
Incubation: 1-5 days at 37°C in a humidified 5% CO2 atmosphere, until CPE is progressed through 80% of the monolayer. |
Name of Depositor |
J Vinje, CDC, Division of Viral Diseases |
Source |
Human stool sample, Oxford, UK |
References |
Lee TW, Kurtz JB. Prevalence of human astrovirus serotypes in the Oxford region 1976-92, with evidence for two new serotypes. Epidemiol Infect. 1112(1): 187-193, 1994. PubMed: 8119358
|